TMC Life Sciences Bhd (XKLS:0101) Beneish M-Score: -2.23 (As of Jul. 02, 2026)


XKLS:0101 TMC Life Sciences Bhd XKLS:0101
62 GF Score
Price RM0.45
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd Beneish M-Score?

TMC Life Sciences Bhd XKLS:0101 62 Beneish M-Score is -2.23 as of Jul. 02, 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 62/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 631 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 73.38% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.23 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for TMC Life Sciences Bhd's Beneish M-Score or its related term are showing as below:

XKLS:0101' s Beneish M-Score Range Over the Past 10 Years
Min: -3.35   Med: -2.29   Max: -2.04
Current: -2.23

During the past 13 years, the highest Beneish M-Score of TMC Life Sciences Bhd was -2.04. The lowest was -3.35. And the median was -2.29.

TMC Life Sciences Bhd Beneish M-Score Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd Beneish M-Score Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.35 -2.04 -2.18 -2.74 -2.23

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.23 0.00 0.00 0.00

XKLS:0101 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TMC Life Sciences Bhd Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Beneish M-Score falls into.


XKLS:0101
62GF Score
TMC Life Sciences Bhd XKLS:0101
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of TMC Life Sciences Bhd for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.313+0.528 * 1.0746+0.404 * 1.0258+0.892 * 0.9975+0.115 * 0.8333
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.016693-0.327 * 0.9557
=-2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun25) TTM:Last Year (Jun24) TTM:
Total Receivables was RM60.2 Mil.
Revenue was RM345.5 Mil.
Gross Profit was RM227.5 Mil.
Total Current Assets was RM202.5 Mil.
Total Assets was RM1,132.2 Mil.
Property, Plant and Equipment(Net PPE) was RM725.8 Mil.
Depreciation, Depletion and Amortization(DDA) was RM34.1 Mil.
Selling, General, & Admin. Expense(SGA) was RM0.0 Mil.
Total Current Liabilities was RM110.3 Mil.
Long-Term Debt & Capital Lease Obligation was RM143.0 Mil.
Net Income was RM3.6 Mil.
Gross Profit was RM0.0 Mil.
Cash Flow from Operations was RM22.5 Mil.
 Total Receivables was RM45.9 Mil.
Revenue was RM346.4 Mil.
Gross Profit was RM245.1 Mil.
Total Current Assets was RM262.5 Mil.
Total Assets was RM1,189.7 Mil.
Property, Plant and Equipment(Net PPE) was RM718.3 Mil.
Depreciation, Depletion and Amortization(DDA) was RM27.9 Mil.
Selling, General, & Admin. Expense(SGA) was RM0.0 Mil.
Total Current Liabilities was RM98.6 Mil.
Long-Term Debt & Capital Lease Obligation was RM179.9 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(60.176 / 345.538) / (45.946 / 346.418)
=0.174152 / 0.132632
=1.313

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(245.104 / 346.418) / (227.519 / 345.538)
=0.707538 / 0.658449
=1.0746

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (202.481 + 725.778) / 1132.19) / (1 - (262.541 + 718.274) / 1189.723)
=0.180121 / 0.175594
=1.0258

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=345.538 / 346.418
=0.9975

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(27.905 / (27.905 + 718.274)) / (34.101 / (34.101 + 725.778))
=0.037397 / 0.044877
=0.8333

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 345.538) / (0 / 346.418)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((143.024 + 110.312) / 1132.19) / ((179.932 + 98.62) / 1189.723)
=0.223757 / 0.234132
=0.9557

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3.606 - 0 - 22.506) / 1132.19
=-0.016693

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

TMC Life Sciences Bhd has a M-score of -2.23 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.23 mean?
TMC Life Sciences Bhd (XKLS:0101) has a Beneish M-Score of -2.23 as of Jul. 02, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on TMC Life Sciences Bhd and its competitors. According to the industry distribution chart, TMC Life Sciences Bhd ranks #463 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 73.4%.
Is TMC Life Sciences Bhd's Beneish M-Score too high?
TMC Life Sciences Bhd's current Beneish M-Score is -2.23. Based on the distribution chart, TMC Life Sciences Bhd ranks #463 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #463 out of 631 companies for Beneish M-Score. This places TMC Life Sciences Bhd in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on TMC Life Sciences Bhd and its competitors. TMC Life Sciences Bhd's current Beneish M-Score is -2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.45 — trading 27.4% below its estimated fair value. The current Beneish M-Score is -2.23. TMC Life Sciences Bhd's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Beneish M-Score is -2.23 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.45 is trading 27.4% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • Beneish M-Score: -2.23
  • GF Value™: RM0.62 vs. price of RM0.45 (27.4% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
62GF Score

Get the complete analysis for XKLS:0101

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.45
Price
RM0.62
GF Value